VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ERIC 2022 | Advances in our understanding of the factors contributing to Richter’s transformation in CLL

Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, comments on novel findings associated with Richter’s transformation in patients with chronic lymphocytic leukemia (CLL) and how this knowledge can be used to identify specific mechanisms that could be targeted with new therapies. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter